Charles F. Eisenbeis

Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.

Charles F. Eisenbeis, Harkanwal Preet Singh, U Storb · Genes & Development · 1995 · 449 citations · Full text

Life Sciences, Immunology, Molecular Biology +14

Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1.

Abraham L. Brass, Eli W Kehrli, Charles F. Eisenbeis et al. · Genes & Development · 1996 · 242 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2-4 enhancer.

Charles F. Eisenbeis, Harinder Singh, U Storb · Molecular and Cellular Biology · 1993 · 182 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism

Andrew P. Mone, Carolyn Cheney, Amy Banks et al. · Leukemia · 2005 · 114 citations

Life Sciences, Cell Biology, Oncology +16

A Phase 2 Study of Rituximab in Combination with Recombinant Interleukin-2 for Rituximab-Refractory Indolent Non-Hodgkin's Lymphoma

Khuda Dad Khan, Christos Emmanouilides, Don M. Benson et al. · Clinical Cancer Research · 2006 · 102 citations · Full text

Medicine, Immunology, Pharmacology +15